View of REAL-WORLD EVIDENCE FOR THE USE OF SGLT2 INHIBITORS IN PATIENTS WITH TYPE 2 DIABETES AT A MALAYSIAN TERTIARY CARE CENTRE

Return to Article Details REAL-WORLD EVIDENCE FOR THE USE OF SGLT2 INHIBITORS IN PATIENTS WITH TYPE 2 DIABETES AT A MALAYSIAN TERTIARY CARE CENTRE Download Download PDF